SCHEMBL12438231

SCHEMBL12438231

CC1=NOC(CNc2nc(C)cc(Nc3cc(C4CC4)n[nH]3)n2)C1

nearest known ligand 0.42

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 20/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14050704 0.85 IGF1R (0.48) IGF1R
SCHEMBL14050386 0.84 IGF1R (0.49) IGF1R
SCHEMBL12438554 0.79 IGF1R (0.49) IGF1R
SCHEMBL4462436 0.77 IGF1R (0.70) IGF1R
SCHEMBL14162124 0.76 IGF1R (0.49) IGF1R
SCHEMBL14320002 0.76 IGF1R (0.49) IGF1R
SCHEMBL14310345 0.75 IGF1R (0.44) IGF1R
SCHEMBL12439403 0.74 IGF1R (0.49) IGF1R
SCHEMBL11932344 0.74 IGF1R (0.75) IGF1R
SCHEMBL11344820 0.73 IGF1R (0.66) IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1841760-B1 PYRIMIDINE DERIVATIVES AS KINASE MODULATORS AND METHOD OF USE EXELIXIS INC (US) 2011-08-10 EP disclosed
WO-2008076415-A1 METHODS OF USING MEK INHIBITORS EXELIXIS, INC. (US) 2008-06-26 WO disclosed